Key result
Knockdown or pharmacological inhibition of HSP90AA1 significantly impaired DHAV-3 viral entry without affecting viral adsorption, establishing HSP90AA1 as a key mediator of viral endocytosis.
Why the study?
Duck hepatitis A virus type 3 causes acute fatal hepatitis in ducklings, but the molecular basis of host susceptibility remains poorly understood.
HSP90AA1 acts as a key mediator and functional entry receptor for DHAV-3 endocytosis, highlighting it as a potential antiviral target.
Answers are grounded in this paper and cite their sources.
HSP90AA1 inhibition blocks DHAV-3 entry in duck hepatocytes; hypothesis-generating for antiviral targets, requires validation beyond this animal model.
Duck hepatitis A virus type 3 (DHAV-3) causes acute fatal hepatitis in ducklings, yet the molecular basis of host susceptibility remains poorly understood. Using ducklings selectively bred for natural resistance or susceptibility to DHAV-3, we reanalyzed single-cell transcriptomic data, identified endocytosis as a key pathway in infected hepatocytes, and found that HSP90AA1 (encoding heat shock protein 90α) was differentially expressed between resistant and susceptible hosts. Functional assays revealed that knockdown or pharmacological inhibition of HSP90AA1 did not affect viral adsorption but significantly impaired viral entry, indicating that HSP90AA1 mediates viral endocytosis. Mechanistically, DHAV-3 enters cells via clathrin-mediated, dynamin-independent endocytosis. The viral capsid protein VP1 directly binds to cell-surface HSP90AA1, and this interaction is required for efficient viral internalization. Collectively, these results establish HSP90AA1 as a key mediator of DHAV-3 endocytosis and a functional entry receptor, with its differential expression between susceptible and resistant hosts correlating with the observed disparity in viral susceptibility. This study provides new insights into host-picornavirus interactions and highlights HSP90AA1 as a potential target for antiviral intervention against DHAV-3 infection.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied Duck hepatitis A virus type 3 (DHAV-3) infection. Knockdown or pharmacological inhibition of HSP90AA1 vs. Control was evaluated on Viral entry (endocytosis). Knockdown or pharmacological inhibition of HSP90AA1 significantly impaired DHAV-3 viral entry without affecting viral adsorption, establishing HSP90AA1 as a key mediator of viral endocytosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: